FDA issued a Warning Letter to McKesson Corporation Headquarters on 2/7/2019 as a result of this inspection.
483 McKesson Headquarters Jul 2018

483 McKesson Headquarters Jul 2018

Lance De Souza FDA, Jolanna Norton FDA, Aaron Weisbuch FDA$119.00 - Available Now

FDA investigators audited the McKesson Headquarters - San Francisco, CA, United States facility and issued inspectional observations (via FDA 483) on 18 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jul 2018
  • Location: San Francisco, United States
  • FEI: 3014548060
Add To Cart